Helma Pinchemel Cotrim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Helma Pinchemel Cotrim has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Adimeia Souza Santos
1 shared publicationAdriano Rios
1 shared publicationAlessandro De Moura Almeida
Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Avenida Tancredo Neves, Ed. Salvador Trade Center, Torre Norte-Sala 717, Salvador, Bahia 41830-020, Brazil
1 shared publication- Almir Galvão Vieira Bitencourt
Imaging Department A.C.Camargo Cancer Center São Paulo Brazil
1 shared publication Andre Vinicius de Assis Florentino
Faculdade de Ciencias Medicas de Campina Grande
1 shared publicationConsuelo Padilha Vilar
Universidade Federal da Bahia; Universidade Federal de Campina Grande, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 September 2013
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 50 (3) , 180-185
NONALCOHOLIC FATTY LIVER DISEASE IN MENOPAUSAL WOMEN
Context Nonalcoholic Fatty Liver Disease (NAFLD) is common in postmenopausal women. It is associated with metabolic syndrome. However, the influence of hormone replacement therapy in NAFLD development in these women needs to be investigated. This study aimed to describe the clinical characteristics of NAFLD in postmenopausal women, and the relationship between hormone replacement therapy and this disease. Methods From April 2009 to April 2011, 292 postmenopausal women from National Health System from Northeast of Brazil were selected, and 251 were included in this study. Menopause was defined as the absence of menstruation for 12 consecutive months in otherwise healthy women. Criteria to NAFLD included: presence of steatosis on abdominal ultrasound; history of alcohol consumption less than 20 g/day and exclusion of other liver diseases. All women underwent a clinical evaluation. Standard univariate and multivariate analyses were performed to evaluate the results. Results The mean age was 56.5 ± 6.7 years. Hormone replacement therapy was referred by 21.1% (53) women and 78.9% (198) was not. Prevalence of NAFLD was 37.1% (93/251) in postmenopausal women, 26,4% (14/53) in the group with hormone replacement therapy and 39,9% (79/198) without hormone replacement therapy. Gamma-glutamyl transpeptidase (P = 0.001), alanine transaminase (P<0.01), ferritin (P<0.001) and insulin resistance (homeostatic model assessment of insulin resistance ≥3) (P<0.001) were higher in the group of women with NAFLD diagnosis who did not referred the use of hormone replacement therapy. Metabolic syndrome was also more frequent in women with NAFLD, who did not refer hormone replacement therapy. Conclusion In conclusion this data suggests elevated prevalence of NAFLD in postmenopausal women; negative association of hormone replacement therapy and NAFLD.
- 1 September 2013
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 50 (3) , 180-185
Open AccessNONALCOHOLIC FATTY LIVER DISEASE IN MENOPAUSAL WOMEN
Context Nonalcoholic Fatty Liver Disease (NAFLD) is common in postmenopausal women. It is associated with metabolic syndrome. However, the influence of hormone replacement therapy in NAFLD development in these women needs to be investigated. This study aimed to describe the clinical characteristics of NAFLD in postmenopausal women, and the relationship between hormone replacement therapy and this disease. Methods From April 2009 to April 2011, 292 postmenopausal women from National Health System from Northeast of Brazil were selected, and 251 were included in this study. Menopause was defined as the absence of menstruation for 12 consecutive months in otherwise healthy women. Criteria to NAFLD included: presence of steatosis on abdominal ultrasound; history of alcohol consumption less than 20 g/day and exclusion of other liver diseases. All women underwent a clinical evaluation. Standard univariate and multivariate analyses were performed to evaluate the results. Results The mean age was 56.5 ± 6.7 years. Hormone replacement therapy was referred by 21.1% (53) women and 78.9% (198) was not. Prevalence of NAFLD was 37.1% (93/251) in postmenopausal women, 26,4% (14/53) in the group with hormone replacement therapy and 39,9% (79/198) without hormone replacement therapy. Gamma-glutamyl transpeptidase (P = 0.001), alanine transaminase (P<0.01), ferritin (P<0.001) and insulin resistance (homeostatic model assessment of insulin resistance ≥3) (P<0.001) were higher in the group of women with NAFLD diagnosis who did not referred the use of hormone replacement therapy. Metabolic syndrome was also more frequent in women with NAFLD, who did not refer hormone replacement therapy. Conclusion In conclusion this data suggests elevated prevalence of NAFLD in postmenopausal women; negative association of hormone replacement therapy and NAFLD.
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (9) , 1415-1418
Fatty liver disease in severe obese patients: Diagnostic value of abdominal ultrasound
AIM: To evaluate the sensitivity and specificity of abdominal ultrasound (US) for the diagnosis of hepatic steatosis in severe obese subjects and its relation to histological grade of steatosis.
- 1 January 2008
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (9) , 1415-1418
Fatty liver disease in severe obese patients: Diagnostic value of abdominal ultrasound
AIM: To evaluate the sensitivity and specificity of abdominal ultrasound (US) for the diagnosis of hepatic steatosis in severe obese subjects and its relation to histological grade of steatosis.